UNSPSC 51321900: Antihyperlipidemic and hypocholesterolemic amides

Antihyperlipidemic and hypocholesterolemic drugs organic compounds containing the -CO-NH2 radical.

UNSPSC 51321900 Antihyperlipidemic and hypocholesterolemic amides is a Class code encompassing prescription medications and pharmaceutical products that state and local governments procure for emergency medical services, public health programs, and employee health benefit administration. Recent solicitations under this code show state and local buyers acquiring both acute-care medications for emergency response and broader pharmaceutical supply agreements spanning multiple therapeutic categories and distribution channels. The code captures everything from individual medication line items supplied to fire rescue services to cooperative multi-state pharmaceutical procurement frameworks serving dozens of participating jurisdictions through authorized wholesaler networks.

State and local issuing bodies pursuing this code include municipal purchasing departments (the City of Tampa), state health agencies (Texas Health and Human Services Commission), and regional cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance administering purchases for Minnesota and participating states including Oregon). The Tampa Fire Rescue bid (IFB 26P00188, due April 8, 2026) solicited four specific advanced life support medications—Labetalol, Epinephrine, Adenosine, and Diltiazem—with firm pricing, nine-month minimum expiration dates, and a one-year initial contract term valued at $40,000.00, including a 5 percent bid discount for Small Local Business Enterprise participation. The Minnesota cooperative RFP (S1070000015802, due March 26, 2026) sought generic multi-source pharmaceuticals and OTC products from manufacturers willing to work through three authorized wholesalers, with pricing weighted at 75 percent and contract effectiveness set for July 1, 2026. The Texas HHS RFI (HHS0017013, posted March 27, 2026) represented exploratory procurement for direct-to-manufacturer prescription fulfillment capabilities outside traditional pharmacy benefit manager and group purchasing organization channels. Recent activity concentrates in Florida, Texas, and Minnesota, with geographic reach extending to other cooperative purchasing member states.